RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Brigrajac, Here's the reply from the company, looks like it will be Q4-2015 for the topline results -



My question -


>>> Dear Cortex,

In hearing the recent webcast of Dr. Lippa's Rodman presentation, some of us investors on the Cortex IHub/Investors Hub site were wondering if you could clarify when the Dronabinol Phase 2b topline results are expected? The presentation slides indicate Q4-2015, but Dr. Lippa's comments seemed to indicate Q4 of 2014. Thanks for any clarification you can provide.

Sincerely, ****

<<<



His reply -


>>> Dear ****,


The top line results are expected in Q4-2015. Sorry for the confusion. If you have any other questions that I might be able to answer, feel free to contact me.


Arnold

--
Arnold Lippa, Ph.D.
Chief Executive Officer
Chairman, Board of Directors
Cortex Pharmaceuticals Inc.
[phone] – direct
[e-mail]
www.cortexpharm.com

<<<